Factor VIII inhibitor development in Egyptian hemophilia patients: does intron 22 inversion mutation play a role?

BACKGROUND: Hemophilia A (HA) is an X-linked recessive bleeding disorder characterized by qualitative and quantitative deficiency of factor VIII (FVIII). The development of inhibitor antibodies against FVIII is the most challenging complication of treatment. Mutations in the FVIII gene is one of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ital J Pediatr
Main Authors: Sherief, Laila M., Gaber, Osama A., Youssef, Hala Mosaad, Sherbiny, Hanan S., Mokhtar, Wesam a, Ali, Asmaa A. A., Kamal, Naglaa M., Abdel Maksoud, Yehia H.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488666/
https://ncbi.nlm.nih.gov/pubmed/32928254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-020-00878-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados